Literature DB >> 12074485

Bacterial pathogens as biological weapons and agents of bioterrorism.

Ronald A Greenfield1, Douglas A Drevets, Linda J Machado, Gene W Voskuhl, Paul Cornea, Michael S Bronze.   

Abstract

Bacterial pathogens have been identified as agents that have been, or could be, used as weapons of biological warfare and/or biological terrorism. These agents are relatively easily obtained, prepared, and dispersed, either as weapons of mass destruction or for more limited terrorist attacks. Although phylogenetically diverse, these agents all have the potential for aerosol dissemination. Physicians in the United States and most of the developed world have never encountered most of these agents and the diseases they produce. Public health programs must be prepared, and individual primary care providers must be able to recognize, diagnose, treat, and prevent infection with these agents.

Entities:  

Mesh:

Year:  2002        PMID: 12074485     DOI: 10.1097/00000441-200206000-00003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  26 in total

1.  Use of 16S rRNA gene sequencing for rapid confirmatory identification of Brucella isolates.

Authors:  Jay E Gee; Barun K De; Paul N Levett; Anne M Whitney; Ryan T Novak; Tanja Popovic
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

2.  The NOD-scid IL2rγnull Mouse Model Is Suitable for the Study of Osteoarticular Brucellosis and Vaccine Safety.

Authors:  Omar H Khalaf; Sankar P Chaki; Daniel G Garcia-Gonzalez; Thomas A Ficht; Angela M Arenas-Gamboa
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

3.  Application of a broad-range resequencing array for detection of pathogens in desert dust samples from Kuwait and Iraq.

Authors:  Tomasz A Leski; Anthony P Malanoski; Michael J Gregory; Baochuan Lin; David A Stenger
Journal:  Appl Environ Microbiol       Date:  2011-05-13       Impact factor: 4.792

4.  Brucella endocarditis - a series of five case reports.

Authors:  I Tammi Raju; Rachana Solanki; A N Patnaik; R C Barik; N R Kumari; A S Gulati
Journal:  Indian Heart J       Date:  2013-01-02

5.  Immunogenicity and safety of subunit plague vaccine: A randomized phase 2a clinical trial.

Authors:  Kai Chu; Jialei Hu; Fanyue Meng; Jingxin Li; Li Luo; Jianjun Xu; Zhonghang Yuan; Zhiyong Li; Wangeng Chen; Lei Jiao; Yali Chang; Bingxiang Wang; Yuemei Hu
Journal:  Hum Vaccin Immunother       Date:  2016-05-09       Impact factor: 3.452

6.  Subversion of innate immune responses by Brucella through the targeted degradation of the TLR signaling adapter, MAL.

Authors:  Dola Sengupta; Alicia Koblansky; Jennifer Gaines; Tim Brown; A Phillip West; Dekai Zhang; Tak Nishikawa; Sung-Gyoo Park; R Martin Roop; Sankar Ghosh
Journal:  J Immunol       Date:  2009-12-14       Impact factor: 5.422

7.  A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plague.

Authors:  Jian Sha; Jason A Rosenzweig; Michelle L Kirtley; Christina J van Lier; Eric C Fitts; Elena V Kozlova; Tatiana E Erova; Bethany L Tiner; Ashok K Chopra
Journal:  Microb Pathog       Date:  2012-10-09       Impact factor: 3.738

8.  Tricky brucellosis.

Authors:  Mojtaba Hedayat Yaghoobi; Bahaoddin Siroos; Morteza Foroumandi; Mehrnaz Asadi Gharabaghi
Journal:  BMJ Case Rep       Date:  2013-05-24

9.  Evaluation of automated and manual commercial DNA extraction methods for recovery of Brucella DNA from suspensions and spiked swabs.

Authors:  Leslie A Dauphin; Rebecca J Hutchins; Liberty A Bost; Michael D Bowen
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

10.  Differentiation of gram-negative bacterial aerosol exposure using detected markers in bronchial-alveolar lavage fluid.

Authors:  David Wunschel; Bobbie-Jo Webb-Robertson; Charles W Frevert; Shawn Skerrett; Nat Beagley; Alan Willse; Heather Colburn; Kathryn Antolick
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.